Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression-Reference-Cited by-同舟云学术

Microbiota modulation by dietary oat beta-glucan prevents steatotic liver disease progression

Published:2024-03 Issue:3 Volume:6 Page:100987
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Jaeger Julius W.,Brandt Annette^ORCID,Gui Wenfang,Yergaliyev Timur^ORCID,Hernández-Arriaga Angélica,Muthu Mukil Marutha,Edlund Karolina,Elashy Ahmed^ORCID,Molinaro Antonio,Möckel Diana,Sarges Jan,Halibasic Emina,Trauner Michael,Kahles Florian,Rolle-Kampczyk Ulrike^ORCID,Hengstler Jan,Schneider Carolin Victoria,Lammers Twan^ORCID,Marschall Hanns-Ulrich^ORCID,von Bergen Martin,Camarinha-Silva Amélia,Bergheim Ina^ORCID,Trautwein Christian,Schneider Kai Markus^ORCID

Publisher

Elsevier BV

Reference66 articles.

1. Mechanisms and disease consequences of nonalcoholic fatty liver disease;Loomba;Cell,2021

2. Evolving role for pharmacotherapy in NAFLD/NASH;Attia;Clin Transl Sci,2021

3. Gut microbiome, liver immunology, and liver diseases;Wang;Cell Mol Immunol,2020

4. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling;Schneider;Nat Metab,2021

5. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: limiting steatohepatitis by maintaining intestinal homeostasis;Schneider;Hepatology,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies;Biomedicines;2024-06-24

2. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration;World Journal of Gastroenterology;2024-05-14

3. Updated mechanisms of MASLD pathogenesis;Lipids in Health and Disease;2024-04-22